Brain scans

Contact us


If you would like to volunteer or learn more about the study, please contact our study team:

Email: cfn.recruitment@imperial.ac.uk

Telephone: +44 (0)20 7594 7028

Or contact our study doctor, Dr Katherine Herlinger, on 07745300960 during working hours (09.00 – 17.00) or via Katherine.Herlinger@nhs.net.

Study overview

In this study, we are investigating the effects of opioid dependence on brain function, with the aim of improving treatment for detoxification and relapse prevention.

Our research uses brain-imaging techniques to detect subtle changes in brain function while performing psychological tasks. These tasks measure brain processes that are important in opioid dependence. We will investigate the effects of aprepitant (for further information, please see Aprepitant Information (.pdf)‌) on brain function in opioid-dependent individuals during methadone treatment, and again, after achieving abstinence from methadone.

We believe that aprepitant could be a useful treatment for relapse prevention or to assist with opiate detoxification by improving these brain processes. We will, therefore, study how aprepitant affects brain responses to the tasks and compare the results with those from a control group who do not have opiate dependence.

Aprepitant is a safe, well-tolerated drug that is licenced for chemotherapy-induced nausea and vomiting.

This study is now Closed to recruitment. 

Accordion widget

Research team

Professor Rebecca Elliott

Professor Rebecca Elliott

Joanna Vamvakopoulou

Joanna Vamvakopoulou
Research Assistant

Ms Alissa Groen

Ms Alissa Groen
MSc Student